Persistent donor derived Vδ4 T cell clones may improve survival for recurrent T cell acute lymphoblastic leukemia after HSCT and DLI

The outcome for T-cell acute lymphoblastic leukemia (T-ALL) in relapse after hematopoietic stem cell transplantation (HSCT) is quite poor, while, both donor lymphocytes infusion (DLI) and adoptively infusion of γδ T cells in leukemia patients after HSCT have demonstrated good results in prolonging s...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Ling, Weng, Jianyu, Huang, Xin, Zeng, Chengwu, Chen, Shaohua, Geng, Suxia, Yang, Lijian, Wu, Suijing, Huang, Suming, Du, Xin, Li, Yangqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper: Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5189998/
https://www.ncbi.nlm.nih.gov/pubmed/27356746
http://dx.doi.org/10.18632/oncotarget.10260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5189998/
https://www.ncbi.nlm.nih.gov/pubmed/27356746
http://dx.doi.org/10.18632/oncotarget.10260

Ejemplares similares